ROCKET AF Results - cardiomil.com.uy
ROCKET AF Results - cardiomil.com.uy
ROCKET AF Results - cardiomil.com.uy
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Efficacy:Summary• Rivaroxaban was non-inferior to warfarin for prevention ofstroke and non-CNS embolism.• Rivaroxaban was superior to warfarin while patients weretaking study drug.• By intention-to-treat, rivaroxaban was non-inferior to warfarinbut did not achieve superiority. Safety:• Similar rates of bleeding and adverse events.• Less ICH and fatal bleeding with rivaroxaban. Conclusion:• Rivaroxaban is a proven alternative to warfarin for moderate orhigh risk patients with <strong>AF</strong>.
Change language